Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Filings indexed 499 across all filing types
Latest filing 2022-03-17 Board/Management Inform…
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Board Change
Board/Management Information Classification · 98% confidence The document is a formal announcement disseminated via RNS (RNS Number: 1719F) from ConvaTec Group PLC. The core subject is the resignation of a Non-Executive Director, Dr. Regina Benjamin, who will step down after the upcoming Annual General Meeting (AGM). This type of announcement, detailing changes in the board of directors or senior management, directly corresponds to the definition of 'Board/Management Information' (MANG). Although it mentions the AGM, the primary focus is the director's departure, not the AGM materials themselves (AGM-R) or the voting results (DVA). It is a specific personnel announcement, making MANG the most accurate classification.
2022-03-17 English
Acquisition Completion of Triad Life Sciences Inc
M&A Activity Classification · 99% confidence The document is very short (2614 characters) and contains an RNS Number, a date, and announces the completion of an acquisition ('ConvaTec Group completes acquisition of Triad Life Sciences Inc'). It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the FCA as a Primary Information Provider. This structure strongly indicates a general regulatory news service announcement that doesn't fit the more specific categories like M&A Activity (TAR) or Capital Change (CAP), but rather serves as a general regulatory disclosure. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-03-14 English
Annual Results
Regulatory Filings Classification · 98% confidence The document is titled 'ConvaTec Group Plc Annual Results for the twelve months ended 31 December 2021' and contains extensive financial tables, key financial highlights (Revenue, Operating profit, EPS), commentary on performance against the previous year (FY2020), and a 2022 outlook. This structure is characteristic of a comprehensive annual financial report. Although it is distributed via RNS (indicated by 'RNS Number : 9917D'), the content itself is the full annual results disclosure, not just a brief announcement of publication. Since the content is the full annual financial performance review, it aligns best with the Annual Report (10-K) definition, even though the company might file a formal 10-K with the SEC later. Given the context of comprehensive annual results, 10-K is the most appropriate classification among the provided options, as 'AR' is defined as standalone audit reports, which this is not. The document is clearly the primary annual financial disclosure.
2022-03-08 English
Non-Executive Director Changes
Board/Management Information Classification · 99% confidence The document is a formal announcement released via RNS (the news service of the London Stock Exchange) on February 28, 2022. The content explicitly details the appointment of a new Non-Executive Director (Sharon O'Keefe) and the resignation of another (Rick Anderson). This directly matches the definition for Board/Management Information (MANG). Although it is an RNS filing, the specific content is about management changes, making MANG the most precise classification over the general RNS code.
2022-02-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' notification from 'ConvaTec Group PLC' dated '10 February 2022'. The form title is 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, specifically when a shareholder crosses or reaches a notification threshold (in this case, crossing 5.082031%). This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-02-10 English
Acquisition: entry into attractive wound biologics
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content details a significant corporate action: the acquisition of Triad Life Sciences Inc. This type of announcement, concerning a major transaction (M&A), is typically classified under the 'Takeover/Acquisition Report' category. Since 'M&A Activity' (TAR) is the closest fit for an acquisition announcement, and the document is a formal regulatory news service release, it is classified as TAR. It is not a general regulatory filing (RNS) because it concerns a specific, defined corporate event (M&A). The document length is substantial (8160 chars), confirming it is the primary announcement, not just a brief notice of publication.
2022-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.